
OPKO Health OPK
€ 0.99
-0.85%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health Allgemeine Reserven 2011-2026 | OPK
Allgemeine Reserven Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.8 M | 65.7 M | 74.1 M | 86.5 M | 132 M | 53.4 M | 42.3 M | 49.3 M | 47.2 M | 39.7 M | 16.6 M | 18.1 M | 22.3 M | 13.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 132 M | 13.3 M | 51.3 M |
Allgemeine Reserven Vierteljährlich OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.3 M | 64 M | 59.4 M | 60.2 M | 59.4 M | 69 M | 73.7 M | 75.4 M | 74.1 M | 71.4 M | - | 99.4 M | 86.5 M | 113 M | 135 M | 159 M | 132 M | 132 M | 132 M | 132 M | 53.4 M | 53.4 M | 53.4 M | 53.4 M | 42.3 M | 42.3 M | 42.3 M | 42.3 M | 49.3 M | 49.3 M | 49.3 M | 49.3 M | 47.2 M | 47.2 M | 47.2 M | 47.2 M | 39.7 M | 39.7 M | 39.7 M | 39.7 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 159 M | 13.3 M | 54.6 M |
Allgemeine Reserven anderer Aktien in der Diagnostik & Forschung
| Name | Allgemeine Reserven | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 15.85 | -2.49 % | $ 171 M | ||
|
Agilent Technologies
A
|
830 M | $ 115.06 | -0.29 % | $ 35 B | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
7.83 M | $ 1.13 | -2.59 % | $ 6.15 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 16.05 | -3.83 % | $ 855 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
992 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 23.13 | -1.28 % | $ 642 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 2.3 | - | $ 10.2 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 175.65 | 0.06 % | $ 8.71 B | ||
|
Danaher Corporation
DHR
|
2.49 B | $ 189.61 | -1.7 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
547 M | $ 120.93 | -2.22 % | $ 19.2 B | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 4.35 | -2.03 % | $ 403 M | ||
|
NeoGenomics
NEO
|
28.6 M | $ 7.69 | -3.17 % | $ 985 M | ||
|
Guardant Health
GH
|
85.9 M | $ 78.6 | -9.83 % | $ 9.85 B | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.13 | -0.9 % | $ 4.89 M | ||
|
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 106.81 | 0.1 % | $ 8.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 260.93 | -4.51 % | $ 21.7 B | ||
|
Natera
NTRA
|
35.4 M | $ 193.03 | -4.91 % | $ 19 B | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 80.59 | -1.03 % | $ 5.44 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 191.51 | -3.19 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.42 | -6.13 % | $ 2.04 B | ||
|
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.94 | -6.97 % | $ 3.89 M | ||
|
Organovo Holdings
ONVO
|
297 K | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
3.65 M | - | -16.95 % | $ 1.54 M |